Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis

Giornale Italiano di Dermatologia e Venereologia

Volumn 147, Issue 6, 2012, Pages 609-624

  Girolomoni, G ^a   Vena, G A ^b   Ayala, F ^c   Cannavo S P ^d   De Pita O ^e   Chimenti, S ^f   Peserico, A ^g  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

Betamethasone; Psoriasis; Skin diseases; Therapeutics

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; HYDROCORTISONE; PLACEBO; TACALCITOL;

COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DEPIGMENTATION; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLICULITIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; MONOTHERAPY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROSACEA; SIDE EFFECT; SKIN ATROPHY; SKIN PRURITUS; TOPICAL TREATMENT; TREATMENT RESPONSE;

EID: 84874364947     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Saraceno R, Gramiccia T, Frascione P, Chimenti S. Calcipotriene/ betamethasone in the treatment of psoriasis: a review article. Expert Opin Pharmacother 2009;10: 2357-65.
2. McCormack PL. Calcipotriol/betamethasone dipropionate. A review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp. Drugs 2011;71:709-30.
3. Kaufmann R, Bibby AJ, Bissonnette R et al. A new calcipotriol/ betamethasone dipropionate formulation (Daivobet®)is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002;205:389-93. (Pubitemid 35356768)
4. Papp KA, Guenther L, Boyden B et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003;48:48-54. (Pubitemid 36091533)
5. Douglas WS, Poulin Y, Decroix J et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002;82:131-5. (Pubitemid 34596689)
6. Ortonne JP, Kaufmann R, Lecha M, Goodfield M. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. Dermatology 2004;209:308-13. (Pubitemid 39482622)
7. Rosina P, Giovannini A, Gisondi P, Girolomoni G. Microcirculatory modifications of psoriatic lesions during topical therapy. Skin Res Technol 2009;15:135-8.
8. Saraceno R, Andreassi L, Ayala F et al. Efficacy, safety and quality of life of calcipotriol /betamethasone dipropionate (Dovobet® versus calcipotriol (Daivonex®) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. J Dermatol Treat 2007;18:361-5. (Pubitemid 350223199)
9. Clareus BW, Houwing R, Sindrup JH, Wigchert S. The DESIRE study - psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice. Eur J Dermatol 2009;19:581-5.
10. Jemec JBE, Ganslandt C, Ortonne JP et al. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. J Am Acad Dermatol 2008;59:455-63.
11. Ortonne JP. Ganslandt C, Tan J et al. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial. J Eur Acad Dermatol Venereol 2009;23:919-26.
12. Kragballe K, Austad J, Barnes L et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris. Br J Dermatol 2006;154:1155-60. (Pubitemid 43727399)
13. Luger TA, Cambazard F, Larsen FG et al. A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis. Dermatology 2008;217:321-8.
14. Fleming C, Ganslandt C, Leese GP. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex®/ Daivobet®/ Dovobet® ointment): hypothalamic-pituitary- adrenal axis function in patients with psoriasis vulgaris. J Drugs Dermatol 2010;9:969-74.
15. Fleming C, Ganslandi C, Guenther L et al. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study. Eur J Dermatol 2010;20:1-7.
16. Langley RGB, Gupta A, Papp K et al. Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial. Dermatology 2011;222:148-56.
17. Queille-Roussel C, Hoffmann V, Ganslandt C, Hansen KK. Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test. Clin Drug Investig 2012;32:613-9.
18. Zaghloul SS, Goodfield MJD. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004;140:408-14. (Pubitemid 38469243)
19. Finlay AY, Edwards PH, Harding KG. "Fingertip unit" in dermatology. Lancet 1989;2:155.
20. Menter A, Korman NJ, Elmets CA et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009;60:643-59.
21. Nast A, Boehncke WH, Mrowietz U et al. German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res 2012;304:87-113.
22. Van der Velden HMJ, Pasch MC, Van Herp PEJ et al. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study. J Dermatol Treat 2010;21:13-22.
23. Vena GA, Cassano N, Agnusdei CP et al. Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea-based emollients. Eur J Inflamm 2005;3:37-41. (Pubitemid 40305722)
24. Reich K, Bewley A. What is new in topical therapy for psoriasis? JEADV 2011;25:15-20.
25. Vena GA, Galluccio A, Pezza M et al. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study. J Dermatol Treat 2011 [Epub ahead of print].